Evidence map›Paper›PMID 36970727›Full record

ArticleCancer research communications2022

The Splicing Factor PTBP1 Represses

William Taylor, Stéphane Deschamps, David Reboutier, Luc Paillard, Agnès Méreau, Yann Audic

Open access · goldFull text read
In one paragraph

Article in Cancer research communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

William TaylorUniv Rennes, CNRS, IGDR (Institut de Genetique et Developpement de Rennes) - UMR 6290, F-35000 Rennes, France.ORCID 0000-0001-9032-847X
Stéphane DeschampsUniv Rennes, CNRS, IGDR (Institut de Genetique et Developpement de Rennes) - UMR 6290, F-35000 Rennes, France.ORCID 0000-0001-6403-235X
David ReboutierUniv Rennes, CNRS, IGDR (Institut de Genetique et Developpement de Rennes) - UMR 6290, F-35000 Rennes, France.ORCID 0000-0002-2587-1844
Luc PaillardUniv Rennes, CNRS, IGDR (Institut de Genetique et Developpement de Rennes) - UMR 6290, F-35000 Rennes, France.ORCID 0000-0002-9290-7616
Agnès Méreau *Univ Rennes, CNRS, IGDR (Institut de Genetique et Developpement de Rennes) - UMR 6290, F-35000 Rennes, France.ORCID 0000-0002-5603-757X
Yann Audic *Univ Rennes, CNRS, IGDR (Institut de Genetique et Developpement de Rennes) - UMR 6290, F-35000 Rennes, France.ORCID 0000-0003-2498-9792
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Significance: Quantifying

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsAlternative SplicingHeterogeneous-Nuclear RibonucleoproteinsHumansPolypyrimidine Tract-Binding ProteinProtein IsoformsRNA Splicing FactorsSquamous Cell Carcinoma of Head and NeckTranscription FactorsTumor Suppressor ProteinsHeterogeneous-Nuclear RibonucleoproteinsPolypyrimidine Tract-Binding ProteinProtein IsoformsPTBP1 protein, humanRNA Splicing FactorsTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID36970727
PMCPMC10035508
OpenAlexW4311626014

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read123
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.